ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3065

Evaluation and Validation of Case-Finding Algorithms for the Identification of Patients with Takayasu’s Arteritis in Large Healthcare Administrative Databases

Narender Annapureddy1, Antoine G. Sreih2, Kevin Byram3, George Casey4, Vince Frangiosa5, Michael George6, Rebecca Sharim5, Sapna Sangani7 and Peter A. Merkel7, 1Rheumatology and Immunology, Vanderbilt University, Nashville, TN, 2Department of Rheumatology, University of Pennsylvania, Philadelphia, PA, 3Internal Medicine, Vanderbilt University, Nashville, TN, 4The Vasculitis Foundation, Kansas City, MO, 5Rheumatology, University of Pennsylvania, Philadelphia, PA, 6Department of Rheumatology, Hospital of the University of Pennsylvania, Philadelphia, PA, 7Penn Vasculitis Center, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: administrative databases and evaluation, Takayasu.s arteritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Vasculitis Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: To facilitate clinical care and
research, validated algorithms are needed to accurately identify patients with
Takayasu’s arteritis (TAK). This study sought to evaluate and validate case-finding
algorithms for TAK in 2 large healthcare administrative databases.

Methods: All adult patients with the International
Classification of Diseases version 9 (ICD9) code for TAK (446.7) were identified
from 2 large healthcare systems (102 from site 1 and 85 from site 2). 26
case-finding algorithms were constructed using a combination of ICD9 code,
encounter type (1 inpatient ICD9 code on 3 consecutive days or 2 outpatient ICD9
codes 3 months apart), physician specialty (Rheumatology, Cardiology, or
Vascular Surgery), use of immunosuppressive medications, age, and sex. The
diagnosis was confirmed by chart review using the ACR classification criteria
or the Chapel Hill Consensus Conference definitions for TAK.

Results: 102 patients from the first healthcare
system (site 1) and 85 patients from the second system (site 2) were included
in the analysis. 47/102 (46%) patients had a confirmed diagnosis of TAK at site
1 and 35/85 (42%) patients at site 2. Table 1 shows the positive and negative
predictive values of the studied algorithms in each healthcare system. An
algorithm including the encounter type, physician specialty, age, and immunosuppressive
medications had the highest average positive predictive value (PPV: 76.9% and
88.2 % respectively). An algorithm including only the physician specialty had
the highest average negative predictive value (NPV: 90.2% and 100%
respectively).

Conclusion: Case-finding algorithms can accurately
identify patients with TAK using large administrative databases. A simple
algorithm including the encounter type, physician specialty, age, and immunosuppressive
medications had the highest positive predictive value. Similarly, an algorithm
including only the physician specialty had the highest negative predictive
value. These algorithms can be used to assemble a population-based cohort of
patients with TAK and facilitate future research in healthcare use, outcomes,
and comparative effectiveness. 

 

Table 1. Test characteristics of Algorithms for Takayasu’s Arteritis

Algorithms for Takayasu’s Arteritis

Site 1 (n=102)

 

Site 2 (n=85)

 

PPV

NPV

 

PPV

NPV

ICD9+

 

 

 

 

 

   Sex

45.7

52.4

 

42.4

63.2

   Age

58.5

75.7

 

64.3

70.2

   Encounter

51.3

69.2

 

74.4

92.9

   Specialty**

70.5

90.2

 

52.2

100.0

   Medications

53.8

56.6

 

47.8

83.3

 

 

 

 

 

 

 

ICD9+Sex+

 

 

 

 

 

 

   Age

 

59.2

66.0

 

73.7

68.2

   Encounter

50.8

61.5

 

72.2

81.6

   Specialty

 

68.0

75.0

 

53.8

78.8

   Medications

50.0

54.9

 

46.3

67.7

 

 

 

 

 

 

 

ICD9+Age+

 

 

 

 

 

 

   Encounter

60.8

68.6

 

83.3

70.1

   Specialty

 

72.9

77.8

 

75.0

72.1

   Medications

64.7

57.6

 

75.0

72.1

   Specialty+Medications

76.9

58.4

 

81.8

73.0

   Encounter +Sex

62.5

64.5

 

85.7

67.6

   Specialty+Sex

71.1

68.8

 

77.8

68.7

   Medications+Sex

66.7

56.7

 

82.4

69.1

 

 

 

 

 

 

 

ICD9+Encounter+      

 

 

 

 

 

 

   Specialty+Medications

76.5

60.0

 

74.4

87.0

   Specialty+Age

 

74.4

71.4

 

83.3

70.1

   Medications+Age

 

64.7

57.6

 

88.2

70.6

   Specialty+Sex

 

52.6

55.4

 

72.2

81.6

   Specialty+Medications+Age*

76.9

58.4

 

88.2

70.6

   Specialty+Medications+Sex

 

75.0

57.8

 

69.7

76.9

   Specialty+Age+Sex

 

71.9

65.7

 

69.7

76.9

   Medications+Age+Sex

 

66.7

56.7

 

85.7

67.6

   Specialty+Medications+Age+Sex

 

77.8

57.0

 

85.7

67.6

 

 

 

 

 

 

 

ICD9+ Specialty+Medications+Age+Sex

 

77.8

57.0

 

82.4

69.1

* Algorithm with the highest average PPV   ** Algorithm with the highest average NPV.

PPV: positive predictive value. NPV: negative predictive value. ICD9: ICD9 code 446.7.

ENCOUNTER: 1 inpatient ICD9 code on 3 consecutive days or 2 ICD9 codes 3 months apart.

SPECIALTY: a Rheumatologist, Cardiologist, or a Vascular Surgeon involved in the care of the patient. MEDICATIONS: an immunosuppressive medication used. AGE: current age < 50. Sex:  = female.

 


Disclosure: N. Annapureddy, None; A. G. Sreih, None; K. Byram, None; G. Casey, None; V. Frangiosa, None; M. George, None; R. Sharim, None; S. Sangani, None; P. A. Merkel, None.

To cite this abstract in AMA style:

Annapureddy N, Sreih AG, Byram K, Casey G, Frangiosa V, George M, Sharim R, Sangani S, Merkel PA. Evaluation and Validation of Case-Finding Algorithms for the Identification of Patients with Takayasu’s Arteritis in Large Healthcare Administrative Databases [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/evaluation-and-validation-of-case-finding-algorithms-for-the-identification-of-patients-with-takayasus-arteritis-in-large-healthcare-administrative-databases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-and-validation-of-case-finding-algorithms-for-the-identification-of-patients-with-takayasus-arteritis-in-large-healthcare-administrative-databases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology